Pharmacokinetics of subcutaneous and intramuscular butorphanol in dogs
- PMID: 7391944
- DOI: 10.1002/jps.2600690715
Pharmacokinetics of subcutaneous and intramuscular butorphanol in dogs
Abstract
Butorphanol tartrate was administered intramuscularly and subcutaneously to adult male and female dogs at a dose of 0.25 mg/kg. No significant absorption lag time and no significant difference bwtween peak intramuscular and subcutaneous serum concentrations were observed. The mean peak serum concentration was 29 ng/ml at mean times of 28 min after subcutaneous administration and 40 min after intramuscular administration. There were no significant differences in the pharmacokinetics of butorphanol in dogs with either route. The serum half-life was 1.62 hr, and the serum clearance was 3.45 liters/kg/hr. The apparent volume of distribution of butorphanol was 7.96 liters/kg. Although considerable inter- and intraanimal variation in Cmax and AUC was observed, there was no significant difference in the area under the serum concentration versus time curves, and the two administration routes were considered bioequivalent.
Similar articles
-
Disposition of parenteral butorphanol in man.Drug Metab Dispos. 1980 Jul-Aug;8(4):230-5. Drug Metab Dispos. 1980. PMID: 6105056
-
Pharmacokinetics and pharmacodynamics comparison between subcutaneous and intravenous butorphanol administration in horses.J Vet Pharmacol Ther. 2015 Aug;38(4):365-74. doi: 10.1111/jvp.12191. Epub 2014 Dec 7. J Vet Pharmacol Ther. 2015. PMID: 25484250 Clinical Trial.
-
Pharmacokinetics and intramuscular bioavailability of a single dose of butorphanol in Asian elephants (Elephas maximus).J Zoo Wildl Med. 2010 Sep;41(3):418-25. doi: 10.1638/2009-0073.1. J Zoo Wildl Med. 2010. PMID: 20945638 Free PMC article.
-
Population pharmacokinetics of butorphanol following intramuscular administration to exercised thoroughbred horses.J Vet Pharmacol Ther. 2024 Sep;47(5):372-379. doi: 10.1111/jvp.13450. Epub 2024 Apr 30. J Vet Pharmacol Ther. 2024. PMID: 38687131
-
Drug therapy reviews: evaluation of butorphanol tartrate.Am J Hosp Pharm. 1979 Dec;36(12):1683-91. Am J Hosp Pharm. 1979. PMID: 393109 Review.
Cited by
-
Pharmacologic Modulation of Noxious Stimulus-evoked Brain Activation in Cynomolgus Macaques Observed with Functional Neuroimaging.J Am Assoc Lab Anim Sci. 2020 Jan 1;59(1):94-103. doi: 10.30802/AALAS-JAALAS-18-000143. Epub 2019 Nov 21. J Am Assoc Lab Anim Sci. 2020. PMID: 31753062 Free PMC article.
-
Dosing protocols to increase the efficacy of butorphanol in dogs.J Vet Pharmacol Ther. 2022 Nov;45(6):516-529. doi: 10.1111/jvp.13095. Epub 2022 Sep 26. J Vet Pharmacol Ther. 2022. PMID: 36164256 Free PMC article.
-
The pharmacological effects of intramuscular administration of alfaxalone combined with medetomidine and butorphanol in dogs.J Vet Med Sci. 2016 Jul 1;78(6):929-36. doi: 10.1292/jvms.15-0159. Epub 2016 Feb 11. J Vet Med Sci. 2016. PMID: 26875835 Free PMC article.
-
Clinical pharmacokinetics of narcotic agonist-antagonist drugs.Clin Pharmacokinet. 1983 Jul-Aug;8(4):332-43. doi: 10.2165/00003088-198308040-00004. Clin Pharmacokinet. 1983. PMID: 6352139 Review. No abstract available.
-
Cardiorespiratory effects of intramuscular alfaxalone combined with low-dose medetomidine and butorphanol in dogs anesthetized with sevoflurane.Open Vet J. 2024 May;14(5):1251-1258. doi: 10.5455/OVJ.2024.v14.i5.20. Epub 2024 May 31. Open Vet J. 2024. PMID: 38938419 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources